Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Pfizer’s Center for Digital Innovation (CDI) is nominated as an «Honored Digital Innovation Company» In the Prix Galien Greece Awards 2023

Shareshare on emailshare on Linkedinshare on FacebookGet link
March 05 2023

Pfizer’s Center for Digital Innovation (CDI) received the high distinction «Honored Digital Innovation Company» award of the word-class Pharmaceuticals Awards, Prix Galien, at the 6th Awards Ceremony, which took place on April 5th 2023, at Athens Concert Hall.

The award, which coincides with the completion of ten years of Prix Galien's presence in Greece, is a recognition of CDI's work in the field of digital innovation in Health sector. This project, which currently engages more than 400 highly qualified young professionals at CDI's site in Thessaloniki, in addition to the development of innovative solutions that change patients’ lives has contributed substantially to the development of Thessaloniki into a global hub of innovation.

Prix Galien _2_0.jpg

From left to right: irene Paganopoulou, Ioanna Georgiou, Eleni Theologou, , Ioulia Despoinoudi, Dimitris Papakonstantinou, Nico Gariboldi, Zachary Ragkoussis, Vivi Ntrigkogia Sofia Sidira, Antonis Fousteris, Mika Papailiou 

"I am honored and proud to accept this award on behalf of everyone at Pfizer's Center for Digital Innovation – from all the colleagues in Thessaloniki and around the world" said Nico Gariboldi, CDI Lead, upon receiving the award, and added: “We feel very proud of our partnership with the innovation ecosystem in Greece. This award is not only for CDI and Pfizer, but also for all our partners, Universities, research centers, foundations and start-ups that we have worked closely during these 3 years to accelerate breakthroughs that change patients' lives."

Stay up to date

Stay tuned for the latest updates. Subscribe to our newsletter

I would like to receive information and updates regarding the Pfizer Center for Digital Innovation in Thessaloniki and other Pfizer initiatives in accordance with Pfizer's Privacy Policy.